Press review
Media
Press articles and media passages dealing with cases of meningiomas linked to Androcur, Lutéran, Lotényl, of testimonies and actions in justices of the victims, of scientific publications.
December 21, 2024
News
Media
Help scandal on the progestogen Androcur: Emmanuelle recounts her fight "trying but essential"
November 24, 2024
News
Legal procedures
Media
Androcur: Amavea files a complaint against X for endangering others and aggravated deception
Press contact
Emmanuelle Huet-Mignaton
contact@amavea.org
06 07 58 67 96
The press kit is available for free download.
-
South West Lotéran, Lotényl: prevention of the risk of reinforced meningioma
Read moreThanks to the results of the study of the Epi-Phare Scientific Interest Grouping, the Méningioma sur-risk in…
: South West Lotéran, Lotényl: prevention of the risk of reinforced meningioma -
What to choose- March 2021- Inform about the risks of the Luteran and Lutenyl
Read moreWhat to choose March 2021 Inform about the risks of Luteran and Lentenyl Find our others…
: what to choose- March 2021- Inform about the risks of Luteran and Lentenyl -
Lotéran, Lotényl and Méningioma: towards better information from patients
Read moreThe taking of Lotéran or Lotényl induces an over-risk of meningioma, which increases with…
: Lotéran, Lotényl and Meningioma: towards better information from patients -
Le Monde February 10, 2021- Méningiomes due to Androcur more difficult to operate
Read moreThe world February 10, 2021- The meningiomas due to the Androcur more difficult to operate on…
: Le Monde February 10, 2021- Meningiomas due to Androcur more difficult to operate
